UroGen Pharma Ltd. - Ordinary Shares (URGN): Price and Financial Metrics
UroGen Pharma Ltd. - Ordinary Shares (URGN)
Today's Latest Price: $32.78 USD
2.05 (6.67%)
Updated Dec 6 4:00pm
Add URGN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
URGN Daily Price Range
URGN 52-Week Price Range
URGN Stock Price Chart More Charts
URGN Price/Volume Stats
| Current price | $32.78 |
| Prev. close | $30.73 |
| Day low | $31.01 |
| Day high | $32.89 |
| 50-day MA | $25.07 |
| 200-day MA | $32.80 |
| 52-week high | $55.49 |
| 52-week low | $20.72 |
| Volume | 137,270 |
| Avg. volume | 203,500 |
| Dividend yield | N/A |
| Market Cap | 685.00M |
UroGen Pharma Ltd. - Ordinary Shares (URGN) Company Bio
UroGen Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing therapies for urological pathologies. The company is developing its product candidates as chemoablation agents, which are designed to remove tumors by non-surgical means, to treat several forms of non-muscle invasive urothelial cancer, including low-grade upper tract urothelial carcinoma, and low-grade bladder cancer. The company was founded in 2004 and is based in Raanana, Israel.
Top Stories View All
Best & Worst Performing Stock Industries for December 6, 2019
Best & Worst Performing Small Cap Stocks for December 6, 2019
Best & Worst Performing Mid Cap Stocks for December 6, 2019
Best & Worst Performing Large Cap Stocks for December 6, 2019
Best & Worst Performing Mega Cap Stocks for December 6, 2019
View All Top Stories
Loading social stream, please wait...